Modified amine hypothesis for the aetiology of affective illness.
D000342:Affective Symptoms / Q000209:etiology; D000588:Amines / Q000134:cerebrospinal fluid / Q000378:metabolism*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001665:Binding Sites; D001679:Biogenic Amines / Q000134:cerebrospinal fluid / Q000378:metabolism; D001714:Bipolar Disorder / Q000134:cerebrospinal fluid / Q000201:enzymology; D001921:Brain / Q000378:metabolism; D003863:Depression / Q000134:cerebrospinal fluid / Q000201:enzymology / Q000209:etiology; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D001523:Mental Disorders / Q000209:etiology*; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D013566:Sympathomimetics / Q000378:metabolism*
D000588:Amines; D000928:Antidepressive Agents; D001679:Biogenic Amines; D010648:Phenylacetates; D013566:Sympathomimetics; D006897:Hydroxyindoleacetic Acid